139 related articles for article (PubMed ID: 3651943)
1. Comparison of one- and two-dose regimens of influenza vaccine for elderly men.
Levine M; Beattie BL; McLean DM
CMAJ; 1987 Oct; 137(8):722-6. PubMed ID: 3651943
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
[TBL] [Abstract][Full Text] [Related]
3. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
[TBL] [Abstract][Full Text] [Related]
4. Dose sparing with intradermal injection of influenza vaccine.
Kenney RT; Frech SA; Muenz LR; Villar CP; Glenn GM
N Engl J Med; 2004 Nov; 351(22):2295-301. PubMed ID: 15525714
[TBL] [Abstract][Full Text] [Related]
5. Serum antibody responses after intradermal vaccination against influenza.
Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
[TBL] [Abstract][Full Text] [Related]
6. Persistence of influenza serum antibodies in humans following immunization with a bivalent A/Victoria and A/New Jersey vaccine.
Boucher DW; Contreras G; Furesz J
Can Med Assoc J; 1979 Apr; 120(7):799-802, 831. PubMed ID: 427686
[TBL] [Abstract][Full Text] [Related]
7. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1).
Schmidt S; Süss J; Oehring H; Schmidt J
Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540
[TBL] [Abstract][Full Text] [Related]
8. Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers.
Iorio AM; Camilloni B; Basileo M; Neri M; Lepri E; Spighi M
Gerontology; 2007; 53(6):411-8. PubMed ID: 17975317
[TBL] [Abstract][Full Text] [Related]
9. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.
Engler RJ; Nelson MR; Klote MM; VanRaden MJ; Huang CY; Cox NJ; Klimov A; Keitel WA; Nichol KL; Carr WW; Treanor JJ;
Arch Intern Med; 2008 Dec; 168(22):2405-14. PubMed ID: 19064822
[TBL] [Abstract][Full Text] [Related]
10. Specific antibody response after influenza immunization in systemic lupus erythematosus.
Abu-Shakra M; Press J; Varsano N; Levy V; Mendelson E; Sukenik S; Buskila D
J Rheumatol; 2002 Dec; 29(12):2555-7. PubMed ID: 12465151
[TBL] [Abstract][Full Text] [Related]
11. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial.
Cools HJ; Gussekloo J; Remmerswaal JE; Remarque EJ; Kroes AC
J Med Virol; 2009 May; 81(5):908-14. PubMed ID: 19319953
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against influenza in patients with rheumatoid arthritis: the effect of rituximab on the humoral response.
Oren S; Mandelboim M; Braun-Moscovici Y; Paran D; Ablin J; Litinsky I; Comaneshter D; Levartovsky D; Mendelson E; Azar R; Wigler I; Balbir-Gurman A; Caspi D; Elkayam O
Ann Rheum Dis; 2008 Jul; 67(7):937-41. PubMed ID: 17981914
[TBL] [Abstract][Full Text] [Related]
13. Immune response to influenza vaccination in community-dwelling Chinese elderly persons.
Hui SL; Chu LW; Peiris JS; Chan KH; Chu D; Tsui W
Vaccine; 2006 Jun; 24(25):5371-80. PubMed ID: 16713661
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children.
Neuzil KM; Jackson LA; Nelson J; Klimov A; Cox N; Bridges CB; Dunn J; DeStefano F; Shay D
J Infect Dis; 2006 Oct; 194(8):1032-9. PubMed ID: 16991077
[TBL] [Abstract][Full Text] [Related]
15. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks.
Buxton JA; Skowronski DM; Ng H; Marion SA; Li Y; King A; Hockin J
J Infect Dis; 2001 Jul; 184(2):188-91. PubMed ID: 11424016
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years.
Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J
J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715
[TBL] [Abstract][Full Text] [Related]
17. Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine.
Zeman AM; Holmes TH; Stamatis S; Tu W; He XS; Bouvier N; Kemble G; Greenberg HB; Lewis DB; Arvin AM; Dekker CL
Pediatr Infect Dis J; 2007 Feb; 26(2):107-15. PubMed ID: 17259871
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
19. A TritonX-100-split virion influenza vaccine is safe and fulfills the committee for proprietary medicinal products (CPMP) recommendations for the European Community for Immunogenicity, in Children, Adults and the Elderly.
Lina B; Fletcher MA; Valette M; Saliou P; Aymard M
Biologicals; 2000 Jun; 28(2):95-103. PubMed ID: 10885616
[TBL] [Abstract][Full Text] [Related]
20. Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination.
Sugimura T; Ito Y; Tananari Y; Ozaki Y; Maeno Y; Yamaoka T; Kudo Y
Vaccine; 2008 May; 26(22):2700-5. PubMed ID: 18436353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]